Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress ...
A study identified two key genes (CTNNA1 and BCL2L13) as suppressors in spread of colorectal cancer, revealing new strategies ...
Nearly three decades since the remarkable cloning of Dolly the sheep, it has all gone quiet on the human cloning front.
News-Medical.Net on MSN
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...
Two researchers at the University of California, Davis, have been awarded a VinFuture Prize in recognition of their work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback